Clinical Trial Update: A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, pharmacokinetics, and efficacy of TLC590 for postsurgical pain management after bunionectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hallux Valgus

Drugs mentioned

• TLC590

Snippet

Sponsor: Taiwan Liposome Company | Conditions: Hallux Valgus | Phase 2 | Status: COMPLETED